DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Catalent Micron Technologies, Inc.
03 1Hetero Labs Limited
04 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
05 2Natco Pharma Limited
06 1ScinoPharm Taiwan Ltd.
07 1Sicor de Mexico S.A. de C.V
08 1Synthimed Labs Private Limited
09 1Zhejiang Hisun Pharmaceutical Co., Ltd.
01 9Letrozole
02 1letrozole
01 2China
02 5India
03 1Mexico
04 1Taiwan
05 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-809
Start Marketing Date : 2007-11-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0014
Start Marketing Date : 2006-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 68554-0039
Start Marketing Date : 1997-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0011
Start Marketing Date : 2012-05-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7701
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-7723
Start Marketing Date : 2016-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1130
Start Marketing Date : 2005-07-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-3376
Start Marketing Date : 2018-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65096-0116
Start Marketing Date : 2018-08-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58623-0099
Start Marketing Date : 2010-08-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Letrozole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Letrozole, including repackagers and relabelers. The FDA regulates Letrozole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Letrozole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Letrozole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Letrozole supplier is an individual or a company that provides Letrozole active pharmaceutical ingredient (API) or Letrozole finished formulations upon request. The Letrozole suppliers may include Letrozole API manufacturers, exporters, distributors and traders.
click here to find a list of Letrozole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Letrozole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Letrozole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Letrozole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Letrozole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Letrozole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Letrozole suppliers with NDC on PharmaCompass.
We have 9 companies offering Letrozole
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
